SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology.
SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology.
复制标题
DOI:
10.1016/j.chom.2017.01.015
复制
发表时间:
2017-03-08
影响因子:
30.3
通讯作者:
Sola I
中科院分区:
文献类型:
--
作者:
Morales L;Oliveros JC;Fernandez-Delgado R;tenOever BR;Enjuanes L;Sola I
Severe acute respiratory syndrome coronavirus (SARS-CoV) causes lethal disease in humans, which is characterized by exacerbated inflammatory response and extensive lung pathology. To address the relevance of small non-coding RNAs in SARS-CoV pathology, we deep sequenced RNAs from the lungs of infected mice and discovered three 18–22 nt small viral RNAs (svRNAs). The three svRNAs were derived from the nsp3 (svRNA-nsp3.1 and -nsp3.2) and N (svRNA-N) genomic regions of SARS-CoV. Biogenesis of CoV svRNAs was RNase III, cell type, and host species independent, but it was dependent on the extent of viral replication. Antagomir-mediated inhibition of svRNA-N significantly reduced in vivo lung pathology and pro-inflammatory cytokine expression. Taken together, these data indicate that svRNAs contribute to SARS-CoV pathogenesis and highlight the potential of svRNA-N antagomirs as antivirals. SARS-CoV small viral RNAs (svRNA) were identified in infected lungs and cell culture SARS-CoV svRNAs biogenesis was RNase III, cell type, and species independent svRNA-N repressed the expression of mRNAs with 3′ UTR specific target sequences svRNA-N inhibition in vivo reduced lung pathology and proinflammatory cytokines SARS-CoV causes exacerbated inflammatory responses, extensive lung pathology, and lethal disease in humans. Morales et al. identify SARS-CoV-encoded small viral RNAs (svRNAs) expressed during lung infection. Virus N gene-derived svRNA (svRNA-N) contributes to enhanced lung inflammatory pathology. Antisense svRNA-N inhibitors significantly reduced pulmonary inflammation during in vivo infection in mice.
登录
查看更多内容
DOI:
10.1038/nrmicro2147
发表时间:
2009-06
期刊:
Nature reviews. Microbiology
影响因子:
--
作者:
通讯作者:
--
影响因子:
3.1
作者:
Regla-Nava JA;Jimenez-Guardeño JM;Nieto-Torres JL;Gallagher TM;Enjuanes L;DeDiego ML
通讯作者:
DeDiego ML
影响因子:
5.4
作者:
Page, Carly;Goicochea, Lindsay;Frieman, Matthew
通讯作者:
Frieman, Matthew
影响因子:
7.6
作者:
Báez-Santos YM;St John SE;Mesecar AD
通讯作者:
Mesecar AD
DOI:
10.1016/s0140-6736(03)13413-7
发表时间:
2003-05-24
期刊:
Lancet (London, England)
影响因子:
--
作者:
Nicholls JM;Poon LL;Lee KC;Ng WF;Lai ST;Leung CY;Chu CM;Hui PK;Mak KL;Lim W;Yan KW;Chan KH;Tsang NC;Guan Y;Yuen KY;Peiris JS
通讯作者:
Peiris JS